Cabozantinib is an oral multi-targeted tyrosine kinase inhibitor with broad-spectrum anticancer activity.
Authentic
Guarantee
Fast Delivery
Privacy Cabozantinib is a broad-spectrum anticancer drug targeting multiple targets, inhibiting at least nine targets including MET, VEGFR1/2/3, ROS1, RET, AX···【More】
Update: 28 Feb,2026Source: BigbearViews: 105
Copyright2024@ BIGBEAR All right reserved Bigbear | Bigbear Pharmaceutical | Bigbear Laos



